Kerri-Ann Millar
2020
In 2020, Kerri-Ann Millar earned a total compensation of $2.2M as Chief Financial Officer at Cue Biopharma, a 390% increase compared to previous year.
Compensation breakdown
| Bonus | $108,063 |
|---|---|
| Option Awards | $1,392,578 |
| Salary | $292,500 |
| Stock Awards | $397,400 |
| Other | $4,092 |
| Total | $2,194,633 |
Millar received $1.4M in option awards, accounting for 63% of the total pay in 2020.
Millar also received $108.1K in bonus, $292.5K in salary, $397.4K in stock awards and $4.1K in other compensation.
Rankings
In 2020, Kerri-Ann Millar's compensation ranked 5,102nd out of 13,090 executives tracked by ExecPay. In other words, Millar earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,102 out of 13,090 | 61st |
Division Manufacturing | 2,086 out of 5,621 | 63rd |
Major group Chemicals And Allied Products | 837 out of 2,254 | 63rd |
Industry group Drugs | 723 out of 1,954 | 63rd |
Industry Pharmaceutical Preparations | 544 out of 1,459 | 63rd |
Source: SEC filing on April 26, 2021.
Millar's colleagues
We found two more compensation records of executives who worked with Kerri-Ann Millar at Cue Biopharma in 2020.